Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-26

Clinical Trial Update: Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy. [NA]

View source ↗

Summary

Nestlé SPN is conducting a clinical trial to evaluate a hydrolyzed rice protein-based formula for growth, tolerance, and health-related quality of life in infan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrolyzed Rice Protein-based Formula (hydrolyzed rice protein-based formula)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Cow Milk Protein Allergy | NA | Status: RECRUITING